Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

ISIS Pharmaceuticals Company Profile (NASDAQ:ISIS)

Consensus Ratings for ISIS Pharmaceuticals (NASDAQ:ISIS) (?)
Ratings Breakdown: 6 Hold Rating(s), 4 Buy Rating(s)
Consensus Rating:Hold (Score: 2.40)
Consensus Price Target: $67.50 (1.18% upside)

Analysts' Ratings History for ISIS Pharmaceuticals (NASDAQ:ISIS)
Show:
DateFirmActionRatingPrice TargetActions
5/4/2015Needham & Company LLCSet Price TargetBuy$80.00 -> $88.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/4/2015Piper JaffraySet Price TargetHold$68.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/13/2015Needham & Company LLCSet Price TargetBuy$80.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/17/2015Janney Montgomery ScottInitiated CoverageNeutral -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/3/2015Deutsche BankLower Price TargetBuy$80.00 -> $78.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/2/2015Stifel NicolausDowngradeBuy -> Hold$66.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/2/2015Brean CapitalDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/4/2015Piper JaffrayDowngradeOverweight -> Neutral$81.00 -> $68.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/3/2015Needham & Company LLCSet Price TargetBuy$80.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/8/2015Needham & Company LLCBoost Price Target$80.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/16/2014JPMorgan Chase & Co.Boost Price TargetNeutral$38.00 -> $65.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/10/2014Piper JaffrayBoost Price Target$62.00 -> $81.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/9/2014LaidlawBoost Price Target$65.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/8/2014Stifel NicolausBoost Price TargetBuy$55.00 -> $66.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/25/2014LaidlawReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/20/2014Piper JaffrayBoost Price TargetOverweight$53.00 -> $62.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/26/2014Leerink SwannInitiated CoverageMarket Perform$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/28/2014BMO Capital MarketsReiterated RatingOutperform$70.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/12/2014LaidlawInitiated CoverageBuy$52.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/23/2014Summer StreetReiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/7/2014JPMorgan Chase & Co.Reiterated RatingNeutral$59.00 -> $38.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/6/2014Piper JaffrayUpgradeNeutral -> Overweight$61.00 -> $42.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/10/2014BMO Capital MarketsReiterated RatingPositiveView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/3/2014Leerink SwannBoost Price Target$33.00 -> $55.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/3/2014Jefferies GroupBoost Price Target$9.00 -> $10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/21/2014Needham & Company LLCReiterated RatingPositive$46.00 -> $61.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/20/2014Canaccord GenuityBoost Price TargetHold$32.00 -> $45.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/22/2014Deutsche BankInitiated CoverageBuy$60.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/26/2013Piper JaffrayUpgradeUnderweight -> Neutral$25.00 -> $38.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/4/2013JPMorgan Chase & Co.Initiated CoverageNeutral$37.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/24/2013Stifel NicolausBoost Price TargetBuy$38.00 -> $45.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/24/2013Canaccord GenuityBoost Price TargetHold$27.00 -> $32.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/24/2013BMO Capital MarketsBoost Price TargetOutperform$31.00 -> $43.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/23/2013Goldman SachsReiterated RatingHold$26.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/23/2013Needham & Company LLCBoost Price TargetPositive$46.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/10/2013Canaccord GenuityBoost Price TargetHold$23.00 -> $27.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/4/2013Goldman SachsInitiated CoverageNeutral$26.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/7/2013Leerink SwannBoost Price Target$18.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/7/2013Canaccord GenuityBoost Price Target$17.00 -> $23.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/23/2013Piper JaffrayDowngradeNeutral -> Underweight$12.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/22/2013BMO Capital MarketsReiterated RatingBuy$31.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/22/2013Needham & Company LLCBoost Price TargetBuy -> Buy$29.00 -> $36.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/25/2013Jefferies GroupReiterated RatingUnderperform$7.00 -> $9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/24/2013BMO Capital MarketsReiterated RatingOutperform$31.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/24/2013Needham & Company LLCBoost Price TargetBuy$20.00 -> $29.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/4/2013Needham & Company LLCReiterated RatingBuy -> Positive$26.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/29/2013 forward)